Bioventus Inc. (NYSE:BVS – Get Rating) Director John A. Bartholdson bought 178,998 shares of the stock in a transaction on Monday, May 22nd. The shares were acquired at an average cost of $2.08 per share, with a total value of $372,315.84. Following the purchase, the director now owns 5,909,136 shares of the company’s stock, valued […]
DURHAM, N.C., May 10, 2023 Bioventus Inc. , a global leader in innovations for active healing, announced today that it has signed a definitive agreement to sell its Wound business,. | May 10, 2023
The purchase of this $250,000 rehabilitation technology was made possible in part by a few anonymous donors as well as the Webb County Commissioners Court.